Skip to content
10-Q

Quarterly Report

OrthoPediatrics Corp KIDS

0001425450-26-000036

← back to feed
Filed
May 1, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 29, 2026 25.68M sh
Shares Diluted Q1 2026 · Mar 31, 2026 23.69M sh
Shares Diluted Q1 2026 · Mar 31, 2025 23.23M sh
Capex Q1 2026 · Mar 31, 2026 $1.76M
Capex Q1 2026 · Mar 31, 2025 $4.23M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$3.29M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$4.16M
Long Term Debt Q1 2026 · Mar 31, 2026 $100.39M
Long Term Debt Q1 2026 · Dec 31, 2025 $99.82M
Short Term Investments Q1 2026 · Mar 31, 2026 $36.62M
Short Term Investments Q1 2026 · Dec 31, 2025 $41.3M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $12.19M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $19.56M
Stockholders Equity Q1 2026 · Mar 31, 2026 $338.71M
Stockholders Equity Q1 2026 · Dec 31, 2025 $346.6M
Stockholders Equity Q1 2026 · Mar 31, 2025 $347.15M
Stockholders Equity Q1 2026 · Dec 31, 2024 $354.57M
Current Liabilities Q1 2026 · Mar 31, 2026 $47.18M
Current Liabilities Q1 2026 · Dec 31, 2025 $46.2M
Total Liabilities Q1 2026 · Mar 31, 2026 $163.48M
Total Liabilities Q1 2026 · Dec 31, 2025 $162.03M
Current Assets Q1 2026 · Mar 31, 2026 $245.87M
Current Assets Q1 2026 · Dec 31, 2025 $256.42M
Total Assets Q1 2026 · Mar 31, 2026 $502.19M
Total Assets Q1 2026 · Dec 31, 2025 $508.63M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.45
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.46
Eps Basic Q1 2026 · Mar 31, 2026 −$0.45
Eps Basic Q1 2026 · Mar 31, 2025 −$0.46
Sga Expense Q1 2026 · Mar 31, 2026 $31.02M
Sga Expense Q1 2026 · Mar 31, 2025 $30.28M
Rd Expense Q1 2026 · Mar 31, 2026 $2.23M
Rd Expense Q1 2026 · Mar 31, 2025 $2.35M
Net Income Q1 2026 · Mar 31, 2026 −$10.69M
Net Income Q1 2026 · Mar 31, 2025 −$10.66M
Operating Income Q1 2026 · Mar 31, 2026 −$8.34M
Operating Income Q1 2026 · Mar 31, 2025 −$10.98M
Gross Profit Q1 2026 · Mar 31, 2026 $43.39M
Gross Profit Q1 2026 · Mar 31, 2025 $38.26M
Revenue Q1 2026 · Mar 31, 2026 $59.36M
Revenue Q1 2026 · Mar 31, 2025 $52.41M